Obstetrics & Gynecology · Birmingham, AL
NPI
1861401929
Since 2006
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
806 Saint Vincents Dr, Suite 500
Birmingham, AL, 35205
Phone (205) 930-1800
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
806 services
Medicare patients, 2024
205
Average age 73
Drug cost, 2024
$110K
1,216 prescriptions
Company payments, 2025
$157
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cynthia Lassiter was code G0328 (colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous), 168 times for 168 patients. In total Cynthia Lassiter billed 806 services in 22 codes, and Medicare paid $37K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 168 | 168 | $17.69 | $2,972 |
| 77063 Mammography | Office | 147 | 146 | $20.70 | $3,044 |
| 77067 Mammography | Office | 146 | 146 | $78.28 | $11K |
| 99214 Office E&M - Established | Office | 138 | 127 | $77.87 | $11K |
| 77080 Standard X-ray | Office | 58 | 58 | $33.36 | $1,935 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 38 | 38 | $34.51 | $1,311 |
| G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Office | 14 | 12 | $10.19 | $143 |
| 76830 Ultrasound - Abdomen and Pelvis | Office | 14 | 14 | $59.11 | $828 |
| 99204 Office E&M - New | Office | 14 | 14 | $107.04 | $1,499 |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 14 | 14 | $38.87 | $544 |
| 76642 Ultrasound - Nonspecific | Office | 13 | 13 | $42.66 | $555 |
| 99213 Office E&M - Established | Office | 11 | 11 | $53.47 | $588 |
By year: 2022 $44K for 798 services; 2023 $44K for 865 services; 2024 $37K for 806 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 168 | 168 | $17.69 | $2,972 |
Medicare prescription drug claims, 2024
In 2024, the drug Cynthia Lassiter prescribed most often to Medicare patients was Progesterone (Progesterone, Micronized), with 260 prescriptions and refills. In total Cynthia Lassiter wrote 1,216 Medicare prescriptions that cost $110K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Progesterone Progesterone, Micronized | 260 | 541 | 67 | $13K |
| Dotti Estradiol | 170 | 291 | 45 | $21K |
| Estradiol (Twice Weekly) Estradiol | 133 | 280 | 47 | $16K |
| Estradiol Generic | 111 | 317 | 64 | $11K |
| Ibandronate Sodium Generic | 59 | 169 | 19 | $2,801 |
| Raloxifene Hcl Generic | 54 | 140 | 15 | $4,183 |
| Valacyclovir Valacyclovir Hcl | 51 | 91 | 20 | $2,674 |
| Clobetasol Propionate Generic | 49 | 56 | 34 | $1,749 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 38 | 44 | 33 | $650 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 22 | 58 | Under 11 | $497 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 21 | 31 | Under 11 | $3,740 |
| Estradiol (Once Weekly) Estradiol | 18 | 31 | Under 11 | $1,706 |
| Alendronate Sodium Generic | 16 | 43 | Under 11 | $153 |
| Fluconazole Generic | 16 | 16 | 15 | $74.74 |
| Gemtesa Vibegron | 12 | 14 | Under 11 | $6,834 |
Brand drugs: 99 claims; generic drugs: 1,117 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cynthia Lassiter $157 ($157 in general payments such as food, travel and fees) from 7 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $38.21.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.